Graz Study on the Risk of Atrial Fibrillation "GRAF"

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

Atrial fibrillation (AF) is the most common clinical arrhythmia. AF is associated with increased risk for stroke due to blood clots formed in the fibrillating atria. Some patient characteristics increase the likelyhood of AF and at the same time the risk of stroke when AF has developed. To reduce the risk of stroke, anticoagulation therapy is recommended in patients with AF and risk factors (such as high blood...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 December 2015.

1 Nov 2011 23 Oct 2011 1 May 2015 1 Jan 2016 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Diagnostic
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts